North Broward Hosp District

Fort Lauderdale, Florida 33316

0 studies enrolling now · 22 studies all time

What they study most

Bacterial Infections, HIV Infections, HIV Seronegativity, Herpes Simplex, Papilloma, Pneumonia, Pneumocystis Carinii, Pregnancy, Pregnancy Complications, Infectious

Studies at this site

• Safety and Effectiveness of Four Anti-HIV Drug Combinations in HIV-Infected Children and Teens — Completed
• A Study to Compare Different Drugs Used to Prevent Serious Bacterial Infections in HIV-Positive Children — Completed
• Comparison of New Anti-HIV Drug Combinations in HIV-Infected Children Who Have Taken Anti-HIV Drugs — Completed
• A Study of Didanosine Use Alone or in Combination With Zidovudine in Infants Exposed to or Infected With HIV — Completed
• A Study on the Management of Combination Anti-HIV Drug Therapy in HIV-Positive Children With Prior Treatment — Completed
• A Study to Compare Two Different Anti-HIV Drug Regimens — Completed
• A Study of Nevirapine for the Prevention of HIV Transmission From Mothers to Their Babies — Completed
• The Effect of Acyclovir Treatment of the Herpes Simplex Virus (HSV) Infection on HIV Levels in the Blood — Completed
• Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission — Completed
• The Effects of Combination Anti-HIV Medication on Human Papillomavirus (HPV) in HIV-Infected Women — Completed
• A Study on the Effect of High-Calorie Infant Formula on Growth and Nutrition in HIV-Infected Infants — Completed
• Long-Term Effects of HIV Exposure and Infection in Children — Completed
• Long-Term Effects of HAART in Youth With Stronger Immune Systems Versus Youth With Weaker Immune Systems — Completed
• A Blood Test to Look at Cells of the Immune System in Healthy Children — Completed
• Evaluation of the Changes in HIV-1 Burden in Peripheral Blood and Lymphoid Tissue Following Zidovudine ( AZT ) Treatment in HIV-1-Infected Patients With CD4+ Cells Between 100 and 500 Cells/mm3. — Completed
• A Study of 1592U89 Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs — Completed
• The Safety and Effectiveness of Nevirapine Plus Lamivudine Plus Other Anti-HIV Drugs — Completed
• A Study of the Safety and Efficacy of Chronically Administered MDL 28,574A in the Treatment of HIV-Infected Patients — Completed
• Safety and Effectiveness of Lamivudine When Given Once a Day Versus Twice a Day in Combination With Other Anti-HIV Drugs in HIV-Infected Adults Who Have Never Received Anti-HIV Drugs — Completed
• A Study to Compare the Safety and Effectiveness of Two Dosing Schedules of Lamivudine in Combination With Two Other Anti-HIV Drugs — Completed
• A Randomized, Double-Blind Active-Controlled, Dose-Ranging Study of the Safety and Efficacy of Chronically Administered MDL 28,574A in the Treatment of HIV-Infected Patients — Completed
• A Multicenter, Double-Blind, Phase III, Adjuvant-Controlled Study of the Effect of 10 Units of HIV-1 Immunogen (Remune) Compared to Incomplete Freund's Adjuvant (IFA) Alone Every 12 Weeks on AIDS-Free Survival in Subjects With HIV Infection and CD4 T-Lymphocytes Between 300 and 549 Cells/microL Rega — Completed